Corteva (NYSE:CTVA) SVP Cornel B. Fuerer acquired 2,000 shares of Corteva stock in a transaction dated Monday, November 4th. The stock was purchased at an average price of $26.13 per share, with a total value of $52,260.00.

NYSE:CTVA opened at $26.20 on Friday. Corteva has a one year low of $24.35 and a one year high of $32.78. The firm’s fifty day moving average is $26.80.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, October 31st. The company reported ($0.39) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.46) by $0.07. The company had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.97 billion. The company’s quarterly revenue was down 1.8% on a year-over-year basis. Equities analysts predict that Corteva will post 1.24 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Friday, November 29th will be paid a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.98%. The ex-dividend date is Wednesday, November 27th.

A number of large investors have recently added to or reduced their stakes in CTVA. Neville Rodie & Shaw Inc. acquired a new position in shares of Corteva in the 2nd quarter valued at $1,659,000. Park National Corp OH acquired a new position in shares of Corteva in the 2nd quarter valued at $1,981,000. Private Asset Management Inc. acquired a new position in shares of Corteva in the 2nd quarter valued at $654,000. Fulton Bank N.A. acquired a new position in shares of Corteva in the 2nd quarter valued at $208,000. Finally, Summit Financial Group Inc. acquired a new position in shares of Corteva in the 2nd quarter valued at $422,000. Hedge funds and other institutional investors own 72.44% of the company’s stock.

CTVA has been the subject of a number of analyst reports. Royal Bank of Canada upgraded shares of Corteva from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $29.00 to $38.00 in a research note on Friday, August 9th. Zacks Investment Research upgraded shares of Corteva from a “sell” rating to a “hold” rating in a research note on Friday, November 1st. SunTrust Banks reduced their price objective on shares of Corteva from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Friday, October 11th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $30.00 to $27.00 in a research note on Friday, November 1st. Finally, Deutsche Bank boosted their price objective on shares of Corteva from $32.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $31.50.

Corteva Company Profile

Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.

Further Reading: What is Call Option Volume?

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.